Inovio Pharma Q2 Loss Narrows - Quick Facts

(RTTNews) - Inovio Pharmaceuticals, Inc. (INO) reported second-quarter net loss attributable to stockholders of $6.2 million, or $0.09 per share, narrower than $10.7 million or $0.19 per share, prior year.

On average, five analysts polled by Thomson Reuters expected the company to report a loss of $0.13 per share. Analysts' estimates typically exclude special items.

Total revenue was $5.29 million, compared to $3.80 million, last year. The increase in revenue was primarily due to the $3.0 million milestone payment earned in the second quarter 2015 under our partnership agreement with Roche. Analysts expected revenue of $5.52 million for the quarter.